| 000 | 00937 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250517184803.0 | ||
| 264 | 0 | _c20190314 | |
| 008 | 201903s 0 0 eng d | ||
| 022 | _a1095-9203 | ||
| 024 | 7 |
_a10.1126/science.aaq0215 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFeinberg, Mark B | |
| 245 | 0 | 0 |
_aAdvancing dengue vaccine development. _h[electronic resource] |
| 260 |
_bScience (New York, N.Y.) _c11 2017 |
||
| 300 |
_a865-866 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Comment | ||
| 650 | 0 | 4 | _aAntibody-Dependent Enhancement |
| 650 | 0 | 4 |
_aDengue _ximmunology |
| 650 | 0 | 4 |
_aDengue Vaccines _ximmunology |
| 650 | 0 | 4 |
_aDengue Virus _ximmunology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aSevere Dengue |
| 700 | 1 | _aAhmed, Rafi | |
| 773 | 0 |
_tScience (New York, N.Y.) _gvol. 358 _gno. 6365 _gp. 865-866 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1126/science.aaq0215 _zAvailable from publisher's website |
| 999 |
_c27796939 _d27796939 |
||